@duluthmedspa's sema and tirz pricing claims, fact-checked

@duluthmedspa is advertising telehealth weight loss programs using semaglutide ($58/week) and tirzepatide ($83/week) for the first 12 weeks. While these are legitimate GLP-1 medications, there's more to consider than just the price tag.

What does this video actually claim?

The med spa advertises semaglutide programs at $58/week and tirzepatide at $83/week for initial 12-week periods, both including "free telehealth with physician." They're excluding California residents, which suggests they're operating under specific state regulations or licensing restrictions.

The pricing puts semaglutide at roughly $232/month and tirzepatide at $332/month. That's substantially less than brand-name Wegovy (around $1,300/month) or Mounjaro ($1,000+/month) without insurance coverage.

They're likely offering compounded versions of these medications, which isn't inherently problematic but deserves transparency about what patients are actually getting.

Are these medications actually effective for weight loss?

Both semaglutide and tirzepatide have strong clinical evidence for weight loss. The STEP 1 trial (Wilding et al., NEJM, 2021) found 14.9% body weight reduction with 2.4mg semaglutide over 68 weeks compared to 2.4% with placebo.

Tirzepatide performed even better. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) showed 20.9% weight loss at the highest dose (15mg) over 72 weeks. At the 10mg dose, participants lost 19.5% of body weight.

These aren't modest effects. Both medications work by mimicking hormones that regulate blood sugar and slow gastric emptying, leading to reduced appetite and calorie intake.

What's missing from their pitch?

The video doesn't mention side effects, which affect most people starting these medications. Nausea occurs in 15-20% of patients on semaglutide, with vomiting, diarrhea, and constipation also common.

More importantly, they don't clarify whether they're prescribing FDA-approved medications or compounded versions. Compounded semaglutide and tirzepatide aren't FDA-reviewed for safety or efficacy, though they contain the same active ingredients.

The 12-week timeframe is also misleading. Weight loss typically continues for 60-70 weeks before plateauing. Stopping at 12 weeks means missing most of the benefit, and weight often returns when these medications are discontinued.

How do their prices compare to other options?

At $232-332/month, they're pricing below most telehealth competitors but above some online pharmacies offering compounded versions. Ro and Calibrate typically charge $300-400/month for similar programs.

The real comparison should be with insurance-covered prescriptions. Many insurance plans now cover Wegovy or Mounjaro for weight loss, potentially reducing costs to $25-50/month with prior authorization.

Their pricing suggests they're not billing insurance, which limits patient options and potentially costs more long-term than working with a covered provider.

What should you actually know about these programs?

Telehealth weight loss programs can work, but 12 weeks isn't enough time to see full results or establish long-term habits. The STEP and SURMOUNT trials followed patients for over a year because that's how long meaningful weight loss takes.

Ask any provider about their medication source, dosing protocols, and monitoring plans. Legitimate programs include regular check-ins, lab work, and gradual dose increases over months.

Don't focus solely on price. Insurance coverage, medication authenticity, and comprehensive medical oversight matter more than saving money upfront, especially for medications you'll likely need for months or years.